Your Cart ( 1 Item )

• Biologic Therapy for Psoriasis: An Update on the Tumor Necrosis Factor Inhibitors Infliximab, Etanercept, and Adalimumab, and the T-Cell-Targeted Therapies Efalizumab and Alefacept
  September 2005 | Volume 4 | Issue 5 | Original Article | 544 | Copyright © September 2005
  Jeffrey M. Weinberg MD, Clement J. Bottino BA, James Lindholm BA, Robin Buchholz MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs